| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,002 |
920 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
751 |
674 |
$26K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
203 |
195 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
961 |
914 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
127 |
121 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
78 |
78 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
204 |
111 |
$2K |
| 87807 |
|
57 |
55 |
$544.34 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
35 |
31 |
$507.25 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27 |
25 |
$169.95 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
34 |
30 |
$1.16 |